Nationwide Conspiracy Claims OK’d in Generic Drug Pricing Case

The country’s top makers of generic drugs must face a multidistrict lawsuit alleging a nationwide scheme to fix prices, rig bids, and allocate markets through “fair share” agreements, a federal judge ruled.

The consolidated antitrust suit, which grew out of a Department of Justice investigation, targets Actavis Holdco Inc., Endo International PLC, Mylan Inc., Sandoz Inc., Teva Pharmaceuticals USA Inc., and dozens of other drug companies.

It involves overlapping overcharge claims linked to multiple different drugs. The case was filed by nearly every state attorney general, as well as retail pharmacies, pension funds, insurers, drug distributors, ...